NCT04349189View on ClinicalTrials.gov

Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait

CompletedOBSERVATIONAL
Enrollment

119

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

June 20, 2024

Study Completion Date

June 20, 2024

Conditions
Sickle Cell DiseaseVenous ThrombosisSickle Cell TraitHypercoagulable StateVenous Thromboembolism
Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT04349189 - Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait | Biotech Hunter | Biotech Hunter